Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

Hunter, John C., Manandhar, Anuj, Carrasco, Martin A., Gurbani, Deepak, Gondi, Sudershan, Westover, Kenneth D. · 2015 · Molecular Cancer Research

Published version of a preprint

Abstract

KRAS mutations are the most common genetic abnormalities in cancer, but the distribution of specific mutations across cancers and the differential responses of patients with specific KRAS mutations in therapeutic clinical trials suggest that different KRAS mutations have unique biochemical behaviors. To further explain these high-level clinical differences and to explore potential therapeutic strategies for specific KRAS isoforms, we characterized the most common KRAS mutants biochemically for substrate binding kinetics, intrinsic and GTPase-activating protein (GAP)–stimulated GTPase activities, and interactions with the RAS effector, RAF kinase. Of note, KRAS G13D shows rapid nucleotide exchange kinetics compared with other mutants analyzed. This property can be explained by changes in the electrostatic charge distribution of the active site induced by the G13D mutation as shown by X-ray crystallography. High-resolution X-ray structures are also provided for the GDP-bound forms of KRAS G12V, G12R, and Q61L and reveal additional insight. Overall, the structural data and measurements, obtained herein, indicate that measurable biochemical properties provide clues for identifying KRAS-driven tumors that preferentially signal through RAF. Implications: Biochemical profiling and subclassification of KRAS-driven cancers will enable the rational selection of therapies targeting specific KRAS isoforms or specific RAS effectors. Mol Cancer Res; 13(9); 1325–35. ©2015 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-15-0203

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 68 references

Cited by

See all 794

Metadata

Authors
Hunter, J. C., Manandhar, A., Carrasco, M. A., Gurbani, D., Gondi, S., & Westover, K. D.
Affiliations
The University of Texas Southwestern Medical Center (US)
Venue
Molecular Cancer Research
Published
2015-09-01
Volume
13
Issue
9
Pages
1325-1335
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W1953264505
Cited by
786
References
68
Citations by year
2026: 78 · 2025: 118 · 2024: 100 · 2023: 97 · 2022: 109 · 2021: 90 · 2020: 70 · 2019: 46 · 2018: 35 · 2017: 21 · 2016: 19 · 2015: 2
FWCI
11.15
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
KRAS mutation, KRAS G13D, KRAS G12V, KRAS G12R, GTPase activity, Raf kinase, Ras/Raf signaling, KRAS-driven tumors
MeSH terms
Animals, Guanosine Diphosphate, Humans, Mutation, Neoplasms, Proto-Oncogene Proteins p21(ras), Crystallography, X-Ray, GTPase-Activating Proteins, raf Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-15-0203
The paper
Hunter, J. C., Manandhar, A., Carrasco, M. A., Gurbani, D., Gondi, S., & Westover, K. D. (2015). Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-15-0203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.